Skip to main content
ACOG
NASDAQ Life Sciences

Alpha Cognition Appoints New Director to Audit Committee Chair Role

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$5.95
Mkt Cap
$129.556M
52W Low
$4.5
52W High
$11.54
52W Position info
32% above low
Off High info
48% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ACOG sits 32% above its 52-week low of $4.5 on light trading volume (0.3× avg).

Summary

Alpha Cognition Inc. amended a prior 8-K to disclose that new director Bethany Sensenig has been appointed to the Audit and Governance Committees, and will chair the Audit Committee after the upcoming annual meeting.


Key Events · Executive and Board Changes · ACOG

  • New Director Committee Appointments

    Bethany Sensenig, appointed to the Board on April 15, 2026, has now been assigned as a member of the Audit Committee and the Governance and Nomination Committee.

  • Future Audit Committee Chair

    Effective after the annual meeting on June 16, 2026, Ms. Sensenig will assume the critical role of Chair of the Audit Committee.

  • Strengthens Governance

    This amendment clarifies key governance roles for a seasoned biopharmaceutical CFO, which is a positive step for oversight, especially following the company's recent disclosure of a material weakness in its 2025 annual report.


Analysis · ACOG · Life Sciences

This 8-K/A provides crucial details regarding the previously announced appointment of Bethany Sensenig to the Board. Her assignment to the Audit Committee and future role as its Chair are significant, particularly in light of the material weakness in internal controls disclosed in the company's recent 10-K. This move strengthens financial oversight and governance.

How filings like this one have moved

In the 30 days to Sep 18, 2026, 29.2% of the 1713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACOG was trading at $5.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $129.6M. The 52-week trading range was $4.50 to $11.54. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACOG - Latest Insights

ACOG
Sep 16, 2026, 5:57 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.47
Real-time Price: $8.85 info
Change: +$0.380 (+4%) info
Market Cap: $192.734M info
ACOG
Aug 13, 2026, 4:48 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.65
Real-time Price: $8.85 info
Change: -$0.800 (-8%) info
Market Cap: $192.734M info
ACOG
Jul 29, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $8.75
Real-time Price: $8.85 info
Change: +$0.100 (+1%) info
Market Cap: $192.734M info
ACOG
Jul 24, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.90
Real-time Price: $8.85 info
Change: +$0.950 (+12%) info
Market Cap: $192.734M info
ACOG
Jun 29, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $6.81
Real-time Price: $8.85 info
Change: +$2.04 (+30%) info
Market Cap: $192.734M info